| Protein Name: | Acid sphinGOmyelinase-like phosphodiesterase (Q92484) |
|---|---|
| Gene Name: | SMPDL3A |
| Description: | Acid sphinGOmyelinase-like phosphodiesterase 3a precursor (EC 3 1 4 -) (ASM-like phosphodiesterase 3a) |
| PDB ID: | 5EBB |
| Protein Family: | |
| Protein Category: |
This panel provides drug-protein interaction and their ADRs along with references
| Interacting Drugs | Toxicity | Mechanism | Reference |
|---|---|---|---|
| 8-phenyltheophylline | Emesis | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE). [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
| Enprofylline | Emesis | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE) [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
| isobutylmethylxanthine (IBMX) | Emesis | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE). [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
| Theophylline | Emesis | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE). [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
| vehicle | Emesis | Emetic side effect of xanthine bronchodilators results from the inhibition of one or more forms of phosphodiesterase (PDE). [ ADR Type 1 ] | Mechanism for the emetic side effect of xanthine bronchodilators |
This panel provides information on drug category
| Toxicity | Source |
|---|